Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	121.77	247.6	232.94	172.81	238.71
Cash & Short-Term Investments	121.77	247.6	232.94	172.81	238.71
Cash Growth	-50.82%	6.29%	34.80%	-27.61%	35.29%
Accounts Receivable	1,015	1,744	1,560	1,310	1,286
Other Receivables	42.42	46.62	53.43	36.54	20.28
Receivables	1,057	1,790	1,613	1,346	1,306
Inventory	250.78	315.08	247.33	189.03	186.79
Prepaid Expenses	9.89	7.57	11.35	9.56	10.25
Other Current Assets	53.16	8.25	1.86	0.76	-
Total Current Assets	1,493	2,369	2,106	1,719	1,742
Property, Plant & Equipment	271.4	297.54	321.4	306.62	224.77
Long-Term Investments	15.01	13.61	16.2	42.31	23.4
Goodwill	145.04	156.2	162.69	206.96	161.06
Other Intangible Assets	179.4	159.25	138.43	121.92	97.4
Long-Term Accounts Receivable	23.22	26.11	29.62	32.15	33.94
Long-Term Deferred Tax Assets	12.4	3.74	4.82	1.78	0.77
Other Long-Term Assets	8.36	11.85	9	6.29	5.04
Total Assets	2,148	3,037	2,789	2,437	2,289
Accounts Payable	1,486	2,357	2,079	1,662	1,616
Accrued Expenses	72.01	64.5	56.53	49.43	43.48
Current Portion of Long-Term Debt	-	-	0.91	1.15	0.39
Current Portion of Leases	25.2	21.31	26.6	22.06	20.14
Current Income Taxes Payable	7.59	6.03	6.55	6.52	4.59
Other Current Liabilities	20.84	13.66	15.65	13.42	4.3
Total Current Liabilities	1,612	2,462	2,185	1,754	1,689
Long-Term Debt	-	-	0.07	0.97	0.92
Long-Term Leases	158	177.16	187.59	188.6	145.37
Pension & Post-Retirement Benefits	1.46	1.41	1.88	2.01	3.75
Long-Term Deferred Tax Liabilities	7.71	12.94	16.41	19.71	17.63
Other Long-Term Liabilities	-	1.18	1.69	6.46	1.42
Total Liabilities	1,779	2,655	2,392	1,972	1,858
Common Stock	5.11	5.11	5.11	5.09	5.07
Additional Paid-In Capital	347.7	347.19	345.07	340.97	339.73
Retained Earnings	16.33	32.21	32.67	91.58	75.97
Comprehensive Income & Other	-12.28	-16.13	-11.77	-1.93	3.61
Total Common Equity	356.85	368.38	371.08	435.7	424.37
Minority Interest	12.05	13.77	25.04	28.78	5.86
Shareholders' Equity	368.91	382.14	396.12	464.48	430.23
Total Liabilities & Equity	2,148	3,037	2,789	2,437	2,289
Total Debt	183.2	198.47	215.18	212.77	166.81
Net Cash (Debt)	-61.44	49.13	17.76	-39.97	71.9
Net Cash Growth	-	176.64%	-	-	223.81%
Net Cash Per Share	-0.12	0.10	0.03	-0.08	0.14
Filing Date Shares Outstanding	510.87	510.75	510.72	508.7	506.57
Total Common Shares Outstanding	510.87	510.75	510.72	508.7	506.57
Working Capital	-118.75	-93.45	-78.39	-35.81	52.94
Book Value Per Share	0.70	0.72	0.73	0.86	0.84
Tangible Book Value	32.42	52.93	69.97	106.82	165.91
Tangible Book Value Per Share	0.06	0.10	0.14	0.21	0.33
Machinery	104.94	145.73	148.01	131.88	155.63
Leasehold Improvements	129.52	134.68	131.41	113.03	74.47

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.